Lv6235
1800 积分 2023-04-26 加入
Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
21天前
已关闭
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer
23天前
已完结
Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
23天前
已完结
Emerging evidence for adapting radiotherapy to immunotherapy
25天前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer
28天前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
28天前
已完结
PACIFIC-5: Phase III study of durvalumab after either concurrent or sequential chemoradiotherapy (CRT) in patients with stage III NSCLC
28天前
已完结
PACIFIC-5: Phase III study of durvalumab after either concurrent or sequential chemoradiotherapy (CRT) in patients with stage III NSCLC
28天前
已关闭
Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer
1个月前
已完结
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy
1个月前
已完结
皖公网安备34019202002308
